ribociclib
novartis
['natalee', ' ribo']
natalee median f/up 30months. ribo reduced invasive recurrence (primary endpoint) by 25% and similarly ddfs. os data very immature. improved safety with the 400mg dose. , #asco23 
Ασυνάρτητος και ημιτελής. Passionate and perfectionist. Med Onc with special love to Gyn Onc and prostate cancer.